Kimberly-Clark’s agreement to acquire Kenvue will create a U.S. consumer health and hygiene leader with the scale to compete ...

Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...

Kenvue Inc. (NYSE: KVUE) related to its sale to Kimberly-Clark Corporation. Under the terms of the proposed transaction, ...

Add in the steady cash returns from dividend stocks, and you can further increase your potential total returns. With this in ...

On December 5, Guggenheim boosted the firm’s price target on Johnson & Johnson (NYSE:JNJ) to $227 from $206 and maintained a ...

This was the stock's second consecutive day of gains.

KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

These five top blue chip dividend stocks offer growth and income investors a solid opportunity to generate passive income and total return.

Kimberly-Clark (KMB) has quietly slipped over the past 3 months, even as its underlying business keeps growing revenue and ...

The annual 'Judicial Hellholes' report listed Los Angeles as No. 1 due to a $966 million talc verdict and racketeering ...

Neutrogena’s parent company, Kenvue, is consolidating operations to New Jersey. As a result, the Neutrogena office in Los ...

Given the potential for a sizable sell-off, it makes sense for investors to move to S&P 500 Dividend Aristocrat stocks like ...